Bellicum Pharmaceuticals (BLCM) Q2 2023 Earnings

Aug 10Confirmed
Aug 2022
Nov 2022
Q4 2022
Q2 2023
-0.93
-0.66
-0.4
-0.13

Details

Expected EPS
N/A
Actual EPS
-0.24
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Bellicum Pharmaceuticals⁩ (⁦BLCM⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts